Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sevoflurane plus nalbuphine for pediatric enteroscopy
ChiCTR1800017009Phase 4Recruiting
- Sponsor
- Guangzhou Women and Children Medical Center
- Start
- Jul 2018
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of sevoflurane and nalbuphine in None (2 arms), sponsored by Guangzhou Women and Children Medical Center. Primary endpoints: Sevoflurane concentration, Recovery time and 3 more. Started Jul 2018; status: recruiting.
02
Drugs
sevofluranenalbuphine
Beyond the preview
Go deeper on ChiCTR1800017009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800017009.